353 related articles for article (PubMed ID: 17443607)
1. Interventions for the treatment of decreased bone mineral density associated with HIV infection.
Lin D; Rieder MJ
Cochrane Database Syst Rev; 2007 Apr; (2):CD005645. PubMed ID: 17443607
[TBL] [Abstract][Full Text] [Related]
2. Treatment for osteoporosis in people with ß-thalassaemia.
Bhardwaj A; Swe KM; Sinha NK; Osunkwo I
Cochrane Database Syst Rev; 2016 Mar; 3():CD010429. PubMed ID: 26964506
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
[TBL] [Abstract][Full Text] [Related]
4. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
5. Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection.
Mondy K; Powderly WG; Claxton SA; Yarasheski KH; Royal M; Stoneman JS; Hoffmann ME; Tebas P
J Acquir Immune Defic Syndr; 2005 Apr; 38(4):426-31. PubMed ID: 15764959
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate therapy for osteogenesis imperfecta.
Dwan K; Phillipi CA; Steiner RD; Basel D
Cochrane Database Syst Rev; 2014 Jul; (7):CD005088. PubMed ID: 25054949
[TBL] [Abstract][Full Text] [Related]
7. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
O'Donnell S; Cranney A; Wells GA; Adachi JD; Reginster JY
Cochrane Database Syst Rev; 2006 Jul; (3):CD005326. PubMed ID: 16856092
[TBL] [Abstract][Full Text] [Related]
8. Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis?
Sawka AM; Ioannidis G; Papaioannou A; Thabane L; Olszynski WP; Brown JP; Hanley DA; Murray TM; Josse RG; Sebaldt RJ; Petrie A; Tenenhouse A; Goldsmith CH; Boulos P; Kouroukis T; Adachi JD
J Obstet Gynaecol Can; 2005 Aug; 27(8):759-64. PubMed ID: 16287007
[TBL] [Abstract][Full Text] [Related]
9. Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.
Bell JM; Shields MD; Watters J; Hamilton A; Beringer T; Elliott M; Quinlivan R; Tirupathi S; Blackwood B
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010899. PubMed ID: 28117876
[TBL] [Abstract][Full Text] [Related]
10. Is there enough evidence to use bisphosphonates in HIV-infected patients? A systematic review and meta-analysis.
Pinzone MR; Moreno S; Cacopardo B; Nunnari G
AIDS Rev; 2014; 16(4):213-22. PubMed ID: 25300622
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates for osteoporosis in people with cystic fibrosis.
Conwell LS; Chang AB
Cochrane Database Syst Rev; 2012 Apr; (4):CD002010. PubMed ID: 22513903
[TBL] [Abstract][Full Text] [Related]
12. Interventions for preventing bone disease in kidney transplant recipients.
Palmer SC; McGregor DO; Strippoli GF
Cochrane Database Syst Rev; 2007 Jul; (3):CD005015. PubMed ID: 17636784
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate therapy for osteogenesis imperfecta.
Phillipi CA; Remmington T; Steiner RD
Cochrane Database Syst Rev; 2008 Oct; (4):CD005088. PubMed ID: 18843680
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates for osteoporosis in people with cystic fibrosis.
Brenckmann C; Papaioannou A
Cochrane Database Syst Rev; 2001; (4):CD002010. PubMed ID: 11687132
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate use in children with cerebral palsy.
Hurley T; Zareen Z; Stewart P; McDonnell C; McDonald D; Molloy E
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD012756. PubMed ID: 34224134
[TBL] [Abstract][Full Text] [Related]
16. Alendronate Improves Bone Mineral Density in Children and Adolescents Perinatally Infected With Human Immunodeficiency Virus With Low Bone Mineral Density for Age.
Jacobson DL; Lindsey JC; Gordon C; Hazra R; Spiegel H; Ferreira F; Amaral FR; Pagano-Therrien J; Gaur A; George K; Benson J; Siberry GK
Clin Infect Dis; 2020 Aug; 71(5):1281-1288. PubMed ID: 31573608
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates for osteoporosis in people with cystic fibrosis.
Conwell LS; Chang AB
Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD002010. PubMed ID: 24627308
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates for osteoporosis in people with cystic fibrosis.
Conwell LS; Chang AB
Cochrane Database Syst Rev; 2009 Oct; (4):CD002010. PubMed ID: 19821288
[TBL] [Abstract][Full Text] [Related]
19. Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).
Rozenberg S; Lanoy E; Bentata M; Viard JP; Valantin MA; Missy P; Darasteanu I; Roux C; Kolta S; Costagliola D;
AIDS Res Hum Retroviruses; 2012 Sep; 28(9):972-80. PubMed ID: 22353022
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D supplementation for improving bone mineral density in children.
Winzenberg TM; Powell S; Shaw KA; Jones G
Cochrane Database Syst Rev; 2010 Oct; (10):CD006944. PubMed ID: 20927753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
